GPR142 Controls Tryptophan-Induced Insulin and Incretin Hormone Secretion to Improve Glucose Metabolism

GPR142, a putative amino acid receptor, is expressed in pancreatic islets and the gastrointestinal tract, but the ligand affinity and physiological role of this receptor remain obscure. In this study, we show that in addition to L-Tryptophan, GPR142 signaling is also activated by L-Phenylalanine but...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 6; p. e0157298
Main Authors Lin, Hua V, Efanov, Alexander M, Fang, Xiankang, Beavers, Lisa S, Wang, Xuesong, Wang, Jingru, Gonzalez Valcarcel, Isabel C, Ma, Tianwei
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 20.06.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:GPR142, a putative amino acid receptor, is expressed in pancreatic islets and the gastrointestinal tract, but the ligand affinity and physiological role of this receptor remain obscure. In this study, we show that in addition to L-Tryptophan, GPR142 signaling is also activated by L-Phenylalanine but not by other naturally occurring amino acids. Furthermore, we show that Tryptophan and a synthetic GPR142 agonist increase insulin and incretin hormones and improve glucose disposal in mice in a GPR142-dependent manner. In contrast, Phenylalanine improves in vivo glucose disposal independently of GPR142. Noteworthy, refeeding-induced elevations in insulin and glucose-dependent insulinotropic polypeptide are blunted in Gpr142 null mice. In conclusion, these findings demonstrate GPR142 is a Tryptophan receptor critically required for insulin and incretin hormone regulation and suggest GPR142 agonists may be effective therapies that leverage amino acid sensing pathways for the treatment of type 2 diabetes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: All authors are current or former employees and may hold stocks of Eli Lilly & Co. This does not alter their adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: HVL AME ICGV TM. Performed the experiments: HVL AME XF LSB XW JW. Analyzed the data: HVL AME XF LSB XW JW. Contributed reagents/materials/analysis tools: ICGV TM. Wrote the paper: HVL AME.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0157298